Attached files

file filename
EX-99.1 - EX-99.1 - Aspira Women's Health Inc.c617-20141113ex99192bfd1.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

   


Form 8-K

   


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported): November 13, 2014

   


Vermillion, Inc.

(Exact name of registrant as specified in its charter)

   


 

   

 

 

 

Delaware

001-34810

33-0595156

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

 

 

 

 

 

12117 Bee Caves Road Building Three, Suite 100, Austin, TX  78738

(Address of principal executive offices, including zip code)

512.519.0400

(Registrant’s telephone number, including area code)

   


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

   

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

   

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

   

 


 

Item 2.02Results of Operations and Financial Condition.

On November 13, 2014, Vermillion, Inc. (the “Company”) issued a press release reporting financial results for the three and nine months ended September 30, 2014.  A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information provided in this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section.  Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in such filing.

 

Item 9.01Financial Statements and Exhibits. 

 

The following exhibit is being furnished as part of this report.

(d)         Exhibit No.Description

99.1Press Release issued by Vermillion, Inc. on November 13, 2014

 

 

 


 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

Vermillion, Inc.

 

 

 

Date: November 13, 2014

By:

/s/Eric J. Schoen

 

 

Eric J. Schoen

 

 

Vice President, Finance and Chief Accounting Officer

 

 

 


 

EXHIBIT INDEX

  

Exhibit No.       Description

99.1Press Release issued by Vermillion, Inc. on November 13, 2014